• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Sofiniclin Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5752655

Sofiniclin (ABT 894) is an agonist of nicotinic acetylcholine receptor (nAChR). It is used for the research for attention-deficit/hyperactivity disorder (ADHD). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Sofiniclin, Inhibitor
Full Product Name
Sofiniclin
Product Synonym Names
ABT 894
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
244.12
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C10H11Cl2N3
SMILES
ClC1=C(Cl)C=C(N2C[C@]3([H])CN[C@]3([H])C2)C=N1
CAS Number
799279-80-4
Target & IC50
Others
In Vitro
Compared to vehicle monkey, Sofiniclin (0.001 to 0.10mg/kg, p.o.) produces significant reductions in LIDs [1]. Sofiniclin (0.1mg/kg) does not decrease LIDs in monkeys with severe nigrostriatal damage [2].

Product References and Citations for Sofiniclin, inhibitor

Zhang D, et al. ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Mov Disord. 2014 Apr;29(4):508-17.
Zhang D, et al. ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Mov Disord. 2014 Apr;29(4):508-17.
Zhang D, ET AL. alpha7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage. Mov Disord. 2015 Dec;30(14):1901-11.
Zhang D, ET AL. alpha7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage. Mov Disord. 2015 Dec;30(14):1901-11.

Other Notes

Small volumes of Sofiniclin, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Sofiniclin purchase

MBS5752655 is an inhibitor targeting Sofiniclin.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000